52

Jenburkt Pharmaceuticals LtdBOM 524731 Stock Report

Last reporting period 31 Mar, 2024

Updated 31 Oct, 2024

Last price

Market cap $B

0.023

Micro

Exchange

XBOM - Bombay Stock Exchange

View Section: Price ratios

Jenburkt Statements

52

Data from Jenburkt`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

31 Mar, 2024

Next reporting period:

27 Sep, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

05 Nov, 2024

Jenburkt Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-03-31
%

745.02

10.4 %

100

156.64

21.1

588.38

11.6 %

78.9

0

219.34

26.7

430.38

14 %

55.1

157.99

5.5 %

23.8

-1.283

-0.1

25.343

3.1

182.05

7.3 %

26.7

49.19

6.4

132.86

4.7 %

20.3

30.112

4.412

2023-09-30
%

674.65

-3.3 %

100

147.47

24

527.17

0.3 %

76

0

205.54

28.4

377.37

-3.8 %

53.7

149.8

12.6 %

22.2

-1.424

-0.2

21.327

2.9

169.7

7.2 %

24.9

42.796

5.8

126.91

7.7 %

19.1

28.76

4.413

2023-03-31
%

697.65

4.2 %

100

172.19

25.9

525.46

2.6 %

74.1

0

195.66

25.9

392.45

7.8 %

54.5

133

-10.2 %

19.6

-1.869

-0.2

27.192

3.6

158.33

-7 %

22.9

40.452

4.9

117.88

-8 %

18.1

28.198

4.237

2022-09-30
%

669.84

9.3 %

100

157.85

24.1

511.99

11.5 %

75.9

0

192.41

28.1

363.91

3.1 %

53.4

148.08

39.5 %

22.5

-1.8

-0.3

24.04

3.5

170.32

31.5 %

25.8

42.125

6.6

128.19

32.5 %

19.2

27.93

4.59

2022-03-31
%

612.92

-2.2 %

100

153.87

25.9

459.06

-1.6 %

74.1

0

187.29

32.2

352.9

10.6 %

59.5

106.16

-28 %

14.5

-2.221

-0.4

25.632

4.5

129.57

-23.4 %

18.6

32.807

6.4

96.759

-23.3 %

12.2

21.085

4.589

2021-09-30
%

626.88

2.1 %

100

160.48

25.3

466.4

4.3 %

74.7

0

177.62

25.7

318.99

-5.3 %

47.1

147.41

33.9 %

27.6

-2.122

-0.3

23.855

3.4

169.14

29.3 %

30.7

42.93

8.2

126.21

28.5 %

22.4

27.504

4.589

2021-03-31
%

613.78

28.1 %

100

166.78

25.4

447

29.6 %

74.6

0

163.6

26.7

336.92

21.6 %

59.4

110.08

61.9 %

15.2

-2.386

-0.4

23.101

4.3

130.8

52.8 %

19.1

32.573

6

98.226

47 %

13.1

21.408

4.588

2020-09-30
%

479.16

-25 %

100

134.2

30.1

344.96

-26.9 %

69.9

0

160.17

26

276.97

-21.9 %

48.1

67.986

-41.9 %

21.9

-2.35

-0.4

19.984

3.4

85.62

-36.9 %

24.8

18.82

6.2

66.8

-27.8 %

18.6

14.56

4.585

2020-03-31
%

638.72

16.1 %

100

167.03

24.4

471.69

22 %

75.6

0

185.51

31.3

354.63

7.7 %

56.7

117.05

103.9 %

18.9

-2.65

-0.4

21.208

4.3

135.61

79 %

22.8

43.059

7.5

92.552

64.8 %

15.2

20.17

4.588

2019-09-30
%

550.19

100

163.64

28.2

386.55

71.8

0

179.59

26.7

329.15

51.6

57.398

20.2

-2.606

-0.6

20.975

2.5

75.767

22.1

19.623

5.9

56.144

16.2

12.233

4.589

View Section: Balance Sheet